How strong is the warranty of a negative FFR? Comment on long-term outcome after deferred revascularization due to negative fractional flow reserve in intermediate coronary lesions by Weerts et al

Morton J Kern; Arnold H Seto

doi:10.1002/ccd.29483

How strong is the warranty of a negative FFR? Comment on long-term outcome after deferred revascularization due to negative fractional flow reserve in intermediate coronary lesions by Weerts et al

Catheter Cardiovasc Interv. 2021 Feb 1;97(2):257-258. doi: 10.1002/ccd.29483.

Authors

Morton J Kern¹, Arnold H Seto¹

Affiliation

¹ Department of Cardiology, Long Beach Veteran's Administration Medical Center, Long Beach, CA, USA.

PMID: 33587798
DOI: 10.1002/ccd.29483

Abstract

Outcomes of deferred PCI based on negative FFR are generally good. This study demonstrated deferred target lesion failure with FFR >0.80 in 7% and related it to coexistent risk factors, such as multivessel disease, diabetes, and SVG lesions. A negative FFR is only one variable on the continuum of ischemic risk, but in general provides an excellent prognostic tool.

Publication types

Editorial
Comment

MeSH terms

Fractional Flow Reserve, Myocardial*
Humans
Myocardial Revascularization
Percutaneous Coronary Intervention* / adverse effects
Prognosis
Treatment Outcome